OWLT

Owlet Expands Global Footprint with Launch of Medically-Certified Dream Sock™ in the UK and Across Europe

Retrieved on: 
星期二, 六月 11, 2024
Health Technology, Retail, Consumer Electronics, Technology, Apps, Applications, General Health, Women, Medical Devices, Parenting, Men, Children, Baby, Maternity, Specialty, Software, Consumer, Health, Multimedia, Amazon, Base station, Vital signs, Infant, Caregiver, Parent, Safety, Entrepreneurship, UKCA, Android, OWLT, Sleep, IOS

View the full release here: https://www.businesswire.com/news/home/20240611652569/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240611652569/en/
    “We’re beyond proud to launch Dream Sock to caregivers across the UK and Europe and bring millions of parents more reassurance while their baby sleeps,” said Kurt Workman, Owlet Chief Executive Officer and Co-Founder.
  • “Dream Sock is now a global product that is recognized as medically accurate and safe, having undergone regulatory authorizations and certifications within several geographies.
  • Parents across the UK and Europe will also now have access to advanced sleep support features.
  • Dream Sock can also be paired with the Owlet Cam® 2 allowing caregivers to see and hear Baby from anywhere, receive motion notifications, and more.

Owlet to Participate in the 8th Annual Cowen Future of the Consumer Conference

Retrieved on: 
星期四, 五月 23, 2024
General Health, Family, Consumer, Apps, Applications, Medical Devices, Technology, Health Technology, Parenting, Children, Baby, Maternity, Women, Health, Conference, Infant, OWLT, Webcast, Eastern Time Zone

Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announced today its participation in the 8th Annual Cowen Future of the Consumer Conference, being held in New York City on June 4-5, 2024.

Key Points: 
  • Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announced today its participation in the 8th Annual Cowen Future of the Consumer Conference, being held in New York City on June 4-5, 2024.
  • Kurt Workman, Owlet’s Co-Founder and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, are scheduled to present on Wednesday, June 5, 2024 at 10:10 a.m. Eastern Time.
  • Owlet management will also participate in one-on-one meetings with investors.
  • A link to the live webcast of the presentation can be found here and will be available on the Owlet Investor Relations website, investors.owletcare.com .

Owlet Announces UK Medical Certification of Dream Sock®

Retrieved on: 
星期二, 五月 14, 2024
Software, Specialty, Consumer Electronics, Consumer, Apps, Applications, Technology, Medical Devices, Health Technology, Parenting, Retail, Children, Baby, Maternity, Health, Infant, Base station, Parent, UKCA, Babysitting, Sleep, Food, Diagnosis, Foot, Certification, Caregiver, OWLT, CE marking

Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, has received UK medical device certification, following the recent achievement of CE Mark certification.

Key Points: 
  • Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, has received UK medical device certification, following the recent achievement of CE Mark certification.
  • The UKCA certification, granted by a recognized UK-approved body, follows the recent announcement of Owlet’s EU CE mark certification of Dream Sock earlier this month and now provides Owlet with medical device certifications in key UK and European markets where its distribution partners operate.
  • “Owlet is extremely well-positioned to take advantage of both the UKCA and EU medical certifications with key retail partnerships across the European market.
  • Dream Sock, as certified for the UK, is intended for use with healthy infants between 0-18 months and 2.5-13.6 kg.

Owlet Announces Strong First Quarter 2024 Results

Retrieved on: 
星期一, 五月 6, 2024
Wearables, Mobile Technology, Technology, Parenting, Baby, Maternity, Software, Audio, Video, General Health, Consumer, Health, Data Management, FDA, Parent, Infant, Prescription, Entrepreneurship, NPS, OWLT, Operating cost, Caregiver, G&A, Growth, Reinsurance

Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2024.

Key Points: 
  • Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2024.
  • We believe our growing market position and operational health are strong momentum indicators for continued success in 2024.”
    Financial Results for the First Quarter Ended March 31, 2024
    Revenues for the first quarter of 2024 were approximately $14.8 million compared to revenue in the first quarter of 2023 of approximately $10.7M.
  • Operating loss was approximately $5.7 million for the first quarter of 2024, compared to approximately $11.0 million for the first quarter of 2023.
  • Adjusted EBITDA loss was approximately $3.1 million for the first quarter of 2024, compared to approximately $5.8 million for the first quarter of 2023.

Owlet Announces European Medical Certification of Dream SockⓇ

Retrieved on: 
星期四, 五月 2, 2024
General Health, Health, FDA, Parenting, Medical Devices, Children, Baby, Maternity, Consumer, Sale, Base station, Safety, Certification, Food, Parent, Infant, Entrepreneurship, Foot, Babysitting, OWLT, Caregiver, Diagnosis, Sleep, Medical device

Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, announces the EU medical device certification of Dream Sock.

Key Points: 
  • Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, announces the EU medical device certification of Dream Sock.
  • This EU-CE-Mark certification, issued by Owlet’s EU notified body, signifies that Owlet’s Dream Sock has been assessed and certified to meet safety and health requirements set out under EU medical device legislation.
  • With this certification, Owlet plans to expand its medical-device product portfolio to even more caregivers around the world.
  • “Our mission to be there for every parent and every baby becomes even more realized with the European medical certification for Dream Sock,” said Kurt Workman, Owlet Chief Executive Officer and Co-Founder.

Owlet to Participate in Upcoming Investor Conferences

Retrieved on: 
星期三, 五月 1, 2024
Apps, Applications, Technology, Parenting, Children, Baby, Maternity, Specialty, Family, Consumer, Retail, Consumer Electronics, OWLT, Conference, Webcast, Infant, Broadcasting

Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announced today the participation in two upcoming investor conferences.

Key Points: 
  • Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announced today the participation in two upcoming investor conferences.
  • Owlet will participate in the Emerging Growth Conference, being held virtually on May 8, 2024.
  • A link to the live webcast of the fireside chat can be found here , and will be available on the Owlet Investor Relations website, investors.owletcare.com .
  • A link to the live webcast of the fireside chat can be found here , and will be available on the Owlet Investor Relations website, investors.owletcare.com .

Owlet to Report First Quarter 2024 Financial Results on May 6, 2024

Retrieved on: 
星期二, 四月 30, 2024
Baby, Maternity, Other Consumer, Health, General Health, Women, Men, Health Technology, Medical Devices, Family, Consumer, Parenting, Business Wire, OWLT, Access code, Telephone, Infant

Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, will release its first quarter 2024 financial results after the market closes on May 6, 2024.

Key Points: 
  • Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, will release its first quarter 2024 financial results after the market closes on May 6, 2024.
  • Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet’s Investor Relations website at investors.owletcare.com .
  • Owlet’s Chief Executive Officer, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m.
  • To listen to the conference call via live audio webcast, please visit the Events section of Owlet’s Investor Relations website at investors.owletcare.com .

Owlet Forges Groundbreaking Partnership with Wheel to Launch Virtual TeleHealth Services Platform

Retrieved on: 
星期四, 四月 25, 2024
Cardiology, Children, Managed Care, Other Health, Health, Health Technology, Infectious Diseases, Family, Consumer, Telemedicine, Virtual Medicine, Parenting, Respiratory syncytial virus, NICU, Pulse, Insurance, Partnership, Parent, CHD, Infant, Prescription, OWLT, Physician, Congenital heart defect, Caregiver, DME, RSV

Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces a strategic partnership with Wheel , an industry leader in providing virtual patient-centric care.

Key Points: 
  • Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces a strategic partnership with Wheel , an industry leader in providing virtual patient-centric care.
  • “Owlet, in partnership with Wheel, can now enable parents to obtain prescriptions for BabySat directly via Wheel’s online portal and network of physicians.
  • “We’re thrilled to announce our strategic partnership with Owlet, a leader in smart infant monitoring.
  • “Wheel’s virtual care platform helps streamline access to home monitoring, making Owlet’s BabySat pulse oximeter more convenient for new parents than ever before.”
    Detailed information on BabySat and the telehealth services process are available at www.owletcare.com .

Wheel to Power Owlet's New Virtual Health and Prescription Service

Retrieved on: 
星期四, 四月 25, 2024
FDA, Health, Insurance, Partnership, Parent, Infant, Prescription, Babysitting, Mental health, OWLT, Physician, Caregiver, DME, Owlet, Health insurance

AUSTIN, Texas, April 25, 2024 /PRNewswire/ -- Wheel, the virtual care platform powering the future of care, today announced a strategic partnership with Owlet, Inc. ("Owlet") (NYSE:OWLT), the pioneer of smart infant monitoring. As part of this direct-to-consumer virtual offering, Wheel clinicians will provide caregivers with timely prescriptions for BabySat™, Owlet's FDA-cleared pulse oximeter, tailored for infants with pre-existing medical conditions. BabySat empowers caregivers to more effectively monitor their baby's health and collaborate with healthcare providers.

Key Points: 
  • As part of this direct-to-consumer virtual offering, Wheel clinicians will provide caregivers with timely prescriptions for BabySa t ™, Owlet's FDA-cleared pulse oximeter, tailored for infants with pre-existing medical conditions.
  • Owlet joins other prominent consumer brands in recently standing up virtual clinical capabilities as a core component of their innovative health offerings.
  • With Wheel, brands can quickly deploy exceptional direct-to-consumer health experiences that give their customers more choice and more flexibility in their care.
  • The company also recently added high-impact partners to its Integrated Virtual Care Ecosystem, which includes solutions for mental health, home-delivery pharmacy options, and lab and diagnostics services.

Owlet Announces Fourth Quarter and Fiscal Year 2023 Results

Retrieved on: 
星期四, 三月 7, 2024
Apps, Applications, Mobile, Wireless, Technology, Parenting, Baby, Maternity, Specialty, Software, Consumer, Retail, Consumer Electronics, Operating cost, OWLT, FDA, Adjustment, Entrepreneurship, Babysitting, Infant, Net, FY, Cryptocurrency

Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reported financial results for the fourth quarter and fiscal year ended December 31, 2023.

Key Points: 
  • Owlet , Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reported financial results for the fourth quarter and fiscal year ended December 31, 2023.
  • I’m proud of the immense progress our team has made in re-shaping the Company in 2023, and I look forward to continued successes in 2024.”
    Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023
    Revenues for the fourth quarter of 2023 were approximately $21.0 million.
  • Adjusted EBITDA loss was approximately $0.7 million for the fourth quarter of 2023, compared to $15.2 million for the fourth quarter of 2022.
  • Net loss per share was $0.97 for the fourth quarter of 2023, compared to net loss per share of $2.43 for the fourth quarter of 2022.